BSE testing
This article was originally published in The Rose Sheet
Executive Summary
Grant applications for development of diagnostics to detect bovine spongiform encephalopathy in consumer products solicited by FDA in May 21 Federal Register. Research "will provide detection methodology critical to support food surveillance programs designed to keep BSE and other TSEs out of U.S. foods, cosmetics and dietary supplements," FDA says. Approximately $700,000 in FY 2001 funding will be available; agency will support "up to four awards of $100,000 to $200,000 (direct plus indirect costs) per award per year" for three years, notice states. Applications must be submitted by July 5. Under Bush Administration's proposed FY 2002 budget, FDA would receive roughly $18.8 mil. for BSE-related activities, with CFSAN receiving $1.1 mil. and five full-time equivalents (1"The Rose Sheet" April 16, p. 6)
You may also be interested in...
CFSAN FY 2002 Budget Proposes $1.1 Mil. For BSE Food, Cosmetics Review
President Bush's FY 2002 budget proposal for FDA allocates $1.1 mil. for expanded monitoring efforts at the Center for Food Safety & Applied Nutrition to "identify food and cosmetic products containing brain, spinal cord and other specific risk material" potentially related to bovine-spongiform encephalopathy.
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle